Longitudinal analysis of humoral immunity against SARS-CoV-2 Spike in convalescent individuals up to 8 months post-symptom onset

Longitudinal analysis of humoral immunity against SARS-CoV-2 Spike in convalescent individuals up to 8 months post-symptom onset

Summary: With the recent approval of highly effective coronavirus disease 2019 (COVID-19) vaccines, functional and lasting immunity to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is currently under investigation as antibody levels in plasma were shown to decline during convalescence...

Full description

Bibliographic Details
Main Authors: Sai Priya Anand, Jérémie Prévost, Manon Nayrac, Guillaume Beaudoin-Bussières, Mehdi Benlarbi, Romain Gasser, Nathalie Brassard, Annemarie Laumaea, Shang Yu Gong, Catherine Bourassa, Elsa Brunet-Ratnasingham, Halima Medjahed, Gabrielle Gendron-Lepage, Guillaume Goyette, Laurie Gokool, Chantal Morrisseau, Philippe Bégin, Valérie Martel-Laferrière, Cécile Tremblay, Jonathan Richard, Renée Bazin, Ralf Duerr, Daniel E. Kaufmann, Andrés Finzi
Format: Article
Language:English
Published: Elsevier 2021-06-01
Series:Cell Reports Medicine
Subjects:
coronavirus
COVID-19
SARS-CoV-2
Spike glycoproteins
RBD
antibodies
Online Access:http://www.sciencedirect.com/science/article/pii/S266637912100118X

Internet

http://www.sciencedirect.com/science/article/pii/S266637912100118X

Similar Items